Zentiva

Zentiva is a historic Czech pharmaceutical company with over 500 years of heritage, originating from the Black Eagle Pharmacy established in 1488 in Prague. The company is headquartered in Prague and operates in 35 countries with a workforce of nearly 4,800 employees. Since becoming independent in 2018, Zentiva has expanded its presence across Europe and doubled its size within four years. Zentiva focuses on developing, manufacturing, and delivering high-quality, affordable medicines that cater to over 100 million people. Its product portfolio spans major therapeutic areas, including cardiology, diabetes, oncology, respiratory health, and central nervous system disorders. The company emphasizes research and development to innovate in medicine delivery while maintaining high standards of safety and efficacy. Zentiva also engages in strategic partnerships and licensing agreements to enhance its offerings, including biosimilars and natural-based consumer healthcare solutions. Zentiva is committed to being a trusted partner in public health, focusing on sustainability and making a positive societal impact for current and future generations.